The US-based Citadel Equity Fund secured a four-year NT$4.55 billion (US$140.7 million) syndicated loan from nine domestic banks yesterday to fund its investment in a local commercial property, the Industrial Bank of Taiwan (IBT, 台灣工銀) said yesterday.
IBT, one of the nation's three industrial banks, is the loan's leading bank.
"The loan will be allocated to fund Citadel's purchase of a 15-floor commercial building in Taipei, priced at NT$5.2 billion," IBT deputy president Sabrina Wang (王莉) said after the bank held a closed-door contract-signing with Citadel's Hong Kong-based representatives Andrew Fong (方嘉榮) and Scott Cham (湛掀凱).
Wang declined to reveal the loan's benchmarked interest rate, citing confidentiality.
The loan, fully collateralized by Citadel's newly purchased commercial building, made up as much as 87 percent of the closing price because of the building's "excellent location," Wang said.
Citadel set up a Taipei-based special purpose vehicle (SPV) -- Citadel No. 5 Asset Company Ltd -- in June to close the deal, the bank's press release said.
The building is located near the intersection of Jinzhou Street and Jianguo N Road and is scheduled to be completed in March by builder Mei Fu Group (美孚建設), the press release said.
"Citadel is upbeat about the prospect of the local commercial property market, which many foreign buyers believe is relatively cheap right now," Wang said.
Foreign investors have recently geared up to tap commercial property investments, with Citi Property Investors (CPI) Asia Pacific closing two of the largest deals with price tags of NT$9.2 billion and NT$5.5 billion respectively this month.
After closing the third-largest deal by foreign buyers this year, Castle also signed a 15-year lease with Aegon Life Insurance (Taiwan) Inc (
"Castle will be immediately rewarded with an annual 5 percent return rate," Lo said.
He said the commercial property market is expected to boom after March's presidential polls.
Citadel has been keeping a low profile and no officials were available for comment yesterday.
Anonymous sources, however, said that the private equity fund has set up its sixth SPV in Taipei to handle another new commercial property deal.
Founded in 1990, the Chicago-based Citadel manages more than US$15 billion in assets with a combined return growth rate of more than 20 percent.
The firm began aggressively tapping Asian markets two years ago.
The loan's eight other creditors include Farglory Life Insurance Co (
The US dollar on Friday rose against the euro, but pared gains late in a session that was muddied by quarter-end trading, while riskier commodity-led currencies fell sharply after European inflation hit a record high and US consumer spending increased faster than expected. Although the dollar index was showing its biggest quarterly gain since the first quarter 2015, but was registered its first weekly decline in three weeks. Sterling rose against the dollar after falling earlier in the day. The pound last showed four straight sessions of gains followed by wild declines on concerns about Britain’s plan to slash taxes and pay
SAMSUNG DISTANT SECOND: Top local chip fims served nearly two-thirds of the global market in Q2, while Samsung kept South Korea competitive with its 16.5 percent share Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) remained the world’s largest contract chipmaker in the second quarter of the year with a 53.4 percent share of the global pure-play foundry market, the Taipei-based market information advisory firm TrendForce Corp (集邦科技) said in a research report on Tuesday. Despite TSMC’s market share dipping slightly from 53.6 percent in the first quarter, it was still far ahead of its rivals, TrendForce said. TSMC continued to benefit from emerging technologies, such as high-performance computing devices, the Internet of Things and automotive electronics, as it posted US$18.15 billion in sales in the second quarter, up 3.5 percent
Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale in the country, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to disclose the formula for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place from 2020 to last year, adding that the vaccine maker is still “eager” to sell the product to China. The company had “given up”
NATIONAL SECURITY: The nation will adopt ‘very firm’ export controls to keep the PRC military from getting access to advanced technologies, a deputy minister said Taiwan yesterday pledged to work closely with the US and other allies to prevent China’s military from acquiring state-of-the-art technology, as Washington steps up efforts to contain the world’s No. 2 economy. Taiwan, home to the world’s largest semiconductor foundry, will keep its advanced chip development at home, while adopting measures to stop its tech from being used by the Chinese People’s Liberation Army, Deputy Minister of Economic Affairs Chen Chern-chyi (陳正祺) said yesterday. Chen said that while Taiwan’s economy would not be able to decouple from its biggest trade partner, it would implement “very firm” export controls to keep advanced technologies